Abstract 2223: A novel protein nanoparticle antigen delivery platform combined with checkpoint inhibition has curative efficacy in the aggressive B16-F10 melanoma model
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: University of California, Irvine, Stanford University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3083326487
